|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vredenburgh JJ, Desjardins A, Herndon JE
II, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S,
Gururangan S, Wagner M, et al: Phase II trial of bevacizumab and
irinotecan in recurrent malignant glioma. Clin Cancer Res.
13:1253–1259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Turkalp Z, Karamchandani J and Das S: IDH
mutation in glioma: New insights and promises for the future. JAMA
Neurol. 71:1319–1325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang RA: MTA1-a stress response protein: A
master regulator of gene expression and cancer cell behavior.
Cancer Metastasis Rev. 33:1001–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mercer TR, Dinger ME, Sunkin SM, Mehler MF
and Mattick JS: Specific expression of long noncoding RNAs in the
mouse brain. Proc Natl Acad Sci USA. 105:716–721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qureshi IA, Mattick JS and Mehler MF: Long
non-coding RNAs in nervous system function and disease. Brain Res.
1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuevas-Diaz Duran R, Wei H, Kim DH and Wu
JQ: Invited Review: Long non-coding RNAs: Important regulators in
the development, function and disorders of the central nervous
system. Neuropathol Appl Neurobiol. 45:538–556. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang XQ and Leung GK: Long non-coding
RNAs in glioma: Functional roles and clinical perspectives.
Neurochem Int. 77:78–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramos AD, Attenello FJ and Lim DA:
Uncovering the roles of long noncoding RNAs in neural development
and glioma progression. Neurosci Lett. 625:70–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
16
|
Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang
J, Zhou J, Kang C, Li M and Jiang C: Long Noncoding RNA NEAT1,
Regulated by the EGFR pathway, contributes to glioblastoma
progression through the WNT/β-catenin pathway by scaffolding EZH2.
Clin Cancer Res. 24:684–695. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pastori C, Kapranov P, Penas C, Peschansky
V, Volmar CH, Sarkaria JN, Bregy A, Komotar R, St Laurent G, Ayad
NG, et al: The Bromodomain protein BRD4 controls HOTAIR, a long
noncoding RNA essential for glioblastoma proliferation. Proc Natl
Acad Sci USA. 112:8326–8331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al: HOTAIR, a cell
cycle-associated long noncoding RNA and a strong predictor of
survival, is preferentially expressed in classical and mesenchymal
glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mineo M, Ricklefs F, Rooj AK, Lyons SM,
Ivanov P, Ansari KI, Nakano I, Chiocca EA, Godlewski J and Bronisz
A: The Long Non-coding RNA HIF1A-AS2 facilitates the maintenance of
mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell
Rep. 15:2500–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rutka JT, Giblin JR, Dougherty DY, Liu HC,
McCulloch JR, Bell CW, Stern RS, Wilson CB and Rosenblum ML:
Establishment and characterization of five cell lines derived from
human malignant gliomas. Acta Neuropathol. 75:92–103. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang JH, Ma ZX, Huang GH, Xu QF, Xiang Y,
Li N, Sidlauskas K, Zhang EE and Lv SQ: Downregulation of HIF-1a
sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Exp Cell Res. 343:148–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Y, Qiu P and Ji Y: TCGA-assembler:
Open-source software for retrieving and processing TCGA data. Nat
Methods. 11:599–600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing Vienna, Austria: 2012, ISBN 3-900051-07-0, URL
http://www.R-project.org/.
|
|
25
|
RStudio Team, . RStudio: Integrated
Development for R. RStudio, Inc.; Boston, MA: 2015, URL
http://www.rstudio.com/.
|
|
26
|
Zhang Y, He W and Zhang S: Seeking for
correlative genes and signaling pathways with bone metastasis from
breast cancer by integrated analysis. Front Oncol. 9:1382019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Caja L, Bellomo C and Moustakas A:
Transforming growth factor beta and bone morphogenetic protein
actions in brain tumors. FEBS Lett. 589:1588–1597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rohle D, Popovici-Muller J, Palaskas N,
Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B,
Komisopoulou E, et al: An inhibitor of mutant IDH1 delays growth
and promotes differentiation of glioma cells. Science. 340:626–630.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pusch S, Krausert S, Fischer V, Balss J,
Ott M, Schrimpf D, Capper D, Sahm F, Eisel J, Beck AC, et al:
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of
IDH1 mutant astrocytoma in vivo. Acta Neuropathol. 133:629–644.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seno A, Kasai T, Ikeda M, Vaidyanath A,
Masuda J, Mizutani A, Murakami H, Ishikawa T and Seno M:
Characterization of gene expression patterns among artificially
developed cancer stem cells using spherical self-organizing map.
Cancer Inform. 15:163–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tummler C, Snapkov I, Wickstrom M, Moens
U, Ljungblad L, Maria Elfman LH, Winberg JO, Kogner P, Johnsen JI
and Sveinbjørnsson B: Inhibition of chemerin/CMKLR1 axis in
neuroblastoma cells reduces clonogenicity and cell viability in
vitro and impairs tumor growth in vivo. Oncotarget.
8:95135–95151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hofman VJ, Moreilhon C, Brest PD, Lassalle
S, Le Brigand K, Sicard D, Raymond J, Lamarque D, Hébuterne XA,
Mari B, et al: Gene expression profiling in human gastric mucosa
infected with Helicobacter pylori. Mod Pathol. 20:974–989. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang M, Li X, Zhang J, Yang Q, Chen W, Jin
W, Huang YR, Yang R and Gao WQ: AHNAK2 is a novel prognostic marker
and oncogenic protein for clear cell renal cell carcinoma.
Theranostics. 7:1100–1113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thomas C, Henry W, Cuiffo BG, Collmann AY,
Marangoni E, Benhamo V, Bhasin MK, Fan C, Fuhrmann L, Baldwin AS,
et al: Pentraxin-3 is a PI3K signaling target that promotes stem
cell-like traits in basal-like breast cancers. Sci Signal. 10(pii):
eaah46742017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Persano L, Pistollato F, Rampazzo E, Della
Puppa A, Abbadi S, Frasson C, Volpin F, Indraccolo S, Scienza R and
Basso G: BMP2 sensitizes glioblastoma stem-like cells to
Temozolomide by affecting HIF-1α stability and MGMT expression.
Cell Death Dis. 3:e4122012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Fiore R, Fanale D, Drago-Ferrante R,
Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan
V, Tesoriere G and Vento R: Genetic and molecular characterization
of the human osteosarcoma 3AB-OS cancer stem cell line: A possible
model for studying osteosarcoma origin and stemness. J Cell
Physiol. 228:1189–1201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Esparza R, Azad TD, Feroze AH, Mitra SS
and Cheshier SH: Glioblastoma stem cells and stem cell-targeting
immunotherapies. J Neurooncol. 123:449–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sen Z, Zhan XK, Jing J, Yi Z and Wanqi Z:
Chemosensitizing activities of cyclotides from Clitoria ternatea in
paclitaxel-resistant lung cancer cells. Oncol Lett. 5:641–644.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao Q, Cai G, Yu Q, Shen J, Gu Z, Chen J,
Shi W and Shi J: IDH1 mutation diminishes aggressive phenotype in
glioma stem cells. Int J Oncol. 52:270–278. 2018.PubMed/NCBI
|
